• hiPSC-Derived Intestinal Organoids for Advanced Pharmacokine

  2026-06-13

  This study presents a robust, scalable protocol for generating intestinal organoids from human pluripotent stem cells, enabling detailed investigation of drug absorption and cytochrome P450 metabolism in vitro. The approach addresses key limitations of animal models and traditional cell lines, providing a human-relevant system for pharmacokinetic studies and CYP2C19 substrate evaluation.

• PA-824 and Terminal Oxidase Inhibition: Redefining Tuberculo

  2026-06-12

  Explore how PA-824, a bicyclic nitroimidazole derivative, enables advanced tuberculosis assay strategies by uniquely targeting Mycobacterium tuberculosis respiration. This in-depth analysis integrates mechanistic evidence and recent innovations, guiding researchers beyond conventional protocols.

• AO/PI Staining Solution: Precision Fluorescent Cell Viabilit

  2026-06-12

  AO/PI Staining Solution empowers researchers to achieve accurate, impurity-resistant live/dead cell discrimination using advanced fluorescent DNA dyes. Its dual staining workflow surpasses traditional methods, ensuring robust viability assessment even in complex disease models like diabetic nephropathy.

• Temozolomide: Advanced Strategies for DNA Repair and ATRX-De

  2026-06-11

  Explore the advanced applications of Temozolomide, a small-molecule alkylating agent, in DNA repair mechanism research and ATRX-deficient glioma models. Discover nuanced assay design insights and new translational strategies that build upon recent breakthroughs.

• Oligo (dT) 25 Beads: Optimizing Superparamagnetic mRNA Isola

  2026-06-11

  Oligo (dT) 25 Beads enable rapid, high-yield eukaryotic mRNA isolation with unmatched specificity and direct compatibility with sensitive downstream applications. This guide details experimental workflows, troubleshooting strategies, and translational insights to maximize performance in advanced gene expression studies.

• TPCA-1: Selective IKK-2 Inhibitor for NF-κB Pathway Research

  2026-06-10

  TPCA-1 is a potent, selective IKK-2 inhibitor used to dissect NF-κB-mediated inflammation. It demonstrates high selectivity, robust cytokine inhibition, and proven in vivo efficacy in arthritis models.

• Scenario-Driven Insights with MCL-1 Inhibitor A-1210477 (SKU

  2026-06-10

  This article offers an evidence-based, scenario-driven guide for using MCL-1 inhibitor A-1210477 (SKU B6011) to resolve common workflow and interpretation challenges in apoptosis assays. With practical Q&A, validated protocol parameters, and candid vendor selection advice, researchers can optimize their cancer cell viability studies and ensure data reliability with APExBIO’s A-1210477.

• PA-824: Bicyclic Nitroimidazole for Drug-Resistant Tuberculo

  2026-06-09

  PA-824 stands out as a potent bicyclic nitroimidazole derivative for tackling both drug-sensitive and resistant Mycobacterium tuberculosis, enabling robust and reproducible research in challenging TB models. Its dual-action mechanism, DMSO solubility, and high purity make it an essential tool for advanced tuberculosis research and experimental drug development.

• ApoEVs Drive LUAD Metastasis via SOX2 and ALDH1A1 Signaling

  2026-06-09

  This study uncovers how apoptotic extracellular vesicles (apoEVs) from tumor cells promote metastasis and stemness in lung adenocarcinoma (LUAD) by activating SOX2 transcription and the NF-κB pathway via ALDH1A1 transfer. These findings reveal a new mechanism of tumor cell communication, highlighting apoEVs-ALDH1A1 as a potential therapeutic target for LUAD recurrence.

• KG-501 (SKU B8380): Reliable CREB Inhibition for Cell Assays

  2026-06-08

  This article provides a scenario-driven guide to deploying KG-501 (SKU B8380) as a robust transcriptional coactivator disruptor in cell viability and proliferation assays. Drawing from peer-reviewed evidence and practical laboratory challenges, it emphasizes reproducibility, protocol optimization, and vendor reliability for biomedical researchers and technicians.

• AZD0156: ATM Kinase Inhibitor Workflows for Cancer Therapy R

  2026-06-08

  AZD0156 stands out as a highly selective ATM kinase inhibitor, empowering cancer therapy research through precise DNA damage response modulation. This guide demystifies AZD0156’s use in combinatorial assays, metabolic vulnerability exploration, and offers actionable troubleshooting for experimental success.

• Protease Inhibitor Cocktails: Strategic Protection for Trans

  2026-06-07

  This article explores the mechanistic and strategic imperatives of using EDTA-free protease inhibitor cocktails in translational research. By integrating mechanistic insight with workflow guidance, it addresses the preservation of protein integrity in phosphorylation-sensitive and complex biochemical applications. Drawing on recent literature and product innovations, it provides actionable recommendations for researchers aiming to maximize fidelity in protein extraction, immunoassays, and post-translational modification analyses.

• Mapping Nucleosome Distortion in Chromatin with Single-Molec

  2026-06-06

  The referenced study introduces the IDLI computational method, enabling unprecedented mapping of nucleosome structural heterogeneity and distortion at single-molecule resolution across chromatin fibers. These findings reshape our understanding of transcription factor interactions, nucleosome remodeling, and their roles in cell-type-specific gene regulation.

• KR-12 Peptide Engineering: Advances for Antimicrobial Resist

  2026-06-05

  The reference study reviews the rational design and functional expansion of KR-12, a small human-derived antimicrobial peptide, and its derivatives. By engineering structure and delivery, these peptides demonstrate enhanced efficacy against drug-resistant pathogens and biofilms, highlighting their potential in antibiotic resistance research and therapeutic development.

• TECPR1-Driven Lysosomal Repair During Energy Stress: Mechani

  2026-06-05

  This study uncovers a new mechanism for lysosomal membrane repair during energy crisis, identifying TECPR1 as a key mediator that orchestrates membrane tubulation and restoration. These findings deepen our understanding of cellular adaptation to metabolic stress and provide a foundation for future research into lysosome-related metabolic disorders.

15775 records 1/1052 page Next 12345 下5页 Last page